4.5 Article

Activation of the metabolic sensor AMP-activated protein kinase inhibits aquaporin-2 function in kidney principal cells

Journal

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
Volume 311, Issue 5, Pages F890-F900

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajprenal.00308.2016

Keywords

epithelial; PKA; water transport; metformin; mpkCCD(c14)

Funding

  1. Danish Medical Research Council
  2. Lundbeck Foundation
  3. VIDI-Innovational Research Grant from the Netherlands Organization of Scientific Research (NWO-ALW) [864.10.007]
  4. Chinese Scholarship Council
  5. Sanofi Fellowship Grant
  6. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [F32 DK097889, R01 DK084184, R01 DK075048]
  7. University of Southern California/University Kidney Research Organization Kidney Research Center
  8. Pittsburgh Center for Kidney Research [P30 DK079307]
  9. Lundbeck Foundation [R192-2015-804] Funding Source: researchfish
  10. Novo Nordisk Fonden [NNF15OC0016342] Funding Source: researchfish

Ask authors/readers for more resources

Aquaporin-2 (AQP2) is essential to maintain body water homeostasis. AQP2 traffics from intracellular vesicles to the apical membrane of kidney collecting duct principal cells in response to vasopressin [arginine vasopressin (AVP)], a hormone released with low intravascular volume, which causes decreased kidney perfusion. Decreased kidney perfusion activates AMP-activated kinase (AMPK), a metabolic sensor that inhibits the activity of several transport proteins. We hypothesized that AMPK activation also inhibits AQP2 function. These putative AMPK effects could protect interstitial ionic gradients required for urinary concentration during metabolic stress when low intravascular volume induces AVP release. Here we found that short-term AMPK activation by treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR; 75 min) in kidney tissue prevented baseline AQP2 apical accumulation in principal cells, but did not prevent AQP2 apical accumulation in response to the AVP analog desmopressin (dDAVP). Prolonged AMPK activation prevented AQP2 cell membrane accumulation in response to forskolin in mouse collecting duct mpkCCD(c14) cells. Moreover, AMPK inhibition accelerated hypotonic lysis of Xenopus oocytes expressing AQP2. We performed phosphorylation assays to elucidate the mechanism by which AMPK regulates AQP2. Although AMPK weakly phosphorylated immunoprecipitated AQP2 in vitro, no direct AMPK phosphorylation of the AQP2 COOH-terminus was detected by mass spectrometry. AMPK promoted Ser-261 phosphorylation and antagonized dDAVP-dependent phosphorylation of other AQP2 COOH-terminal sites in cells. Our findings suggest an increasing, time-dependent antagonism of AMPK on AQP2 regulation with AICAR-dependent inhibition of cAMP-dependent apical accumulation and AVP-dependent phosphorylation of AQP2. This inhibition likely occurs via a mechanism that does not involve direct AQP2 phosphorylation by AMPK.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available